Local pharma producer Antibiotice is planning a significant investment in the research, development, and production of critical medicines, with a proposed RON 376.8 million.
Ceres Pharma, a Belgian pharmaceutical group, has announced the official completion of the integration process between its Romanian subsidiaries, Dacia Plant and Viva Pharma.
Novartis has over 550 employees in Romania and operates a manufacturing unit in the country.
Turnover was approximately RON 231 million in the first nine months of the year.
Opening of STADA production and supply-chain hub in Turda, Romania, strengthens European security of supply with more than 150 million packs of medicines per year.
Romania's consolidated general budget recorded a deficit of RON 121.77 billion (€23.90 billion), equivalent to 6.40% of GDP, in the first eleven months of 2025, down 0.74 percentage points from 7.15% in the same period of 2024.
A company from the PPC Romania group will construct a natural gas power plant with a capacity of approximately 100 MW on Valea Terovei, on the site of the former UCC - Uzina Cocso Chimică platform in Reșița.
Romanian business managers across key sectors forecast a moderate decline in economic activity for December 2025 to February 2026, according to the latest survey from the INS.
Romanian businesses are facing increased exposure to fiscal and operational risks as customs controls intensify across Europe and nationally, according to EY Romania experts.
State-owned power producer Hidroelectrica has convened an Extraordinary General Meeting of Shareholders (EGMS) for 27 January 2026 to approve a strategic partnership with EDF.